Cargando…
Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection
Alzheimer’s disease (AD) is a common neurodegenerative disorder. The number of patients with AD is projected to reach 152 million by 2050. Donepezil, rivastigmine, galantamine, and memantine are the only four drugs currently approved by the United States Food and Drug Administration for AD treatment...
Autores principales: | Jiaranaikulwanitch, Jutamas, Pandith, Hataichanok, Tadtong, Sarin, Thammarat, Phanit, Jiranusornkul, Supat, Chauthong, Nattapong, Nilkosol, Supitcha, Vajragupta, Opa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999550/ https://www.ncbi.nlm.nih.gov/pubmed/33809092 http://dx.doi.org/10.3390/molecules26061562 |
Ejemplares similares
-
From BACE1 Inhibitor to Multifunctionality of Tryptoline and Tryptamine Triazole Derivatives for Alzheimer’s Disease
por: Jiaranaikulwanitch, Jutamas, et al.
Publicado: (2012) -
Potential Anti-Alzheimer Agents from Guanidinyl Tryptophan Derivatives with Activities of Membrane Adhesion and Conformational Transition Inhibitions
por: Wongrattanakamon, Pathomwat, et al.
Publicado: (2021) -
Validated HPTLC and antioxidant activities for quality control of catechin in a fermented tea (Camellia sinensis var. assamica)
por: Thammarat, Phanit, et al.
Publicado: (2021) -
Discovery of Natural Lead Compound from Dendrobium sp. against SARS-CoV-2 Infection
por: Jiaranaikulwanitch, Jutamas, et al.
Publicado: (2022) -
A Stability-Indicating Assay for Tetrahydrocurcumin-Diglutaric Acid and Its Applications to Evaluate Bioaccessibility in an In Vitro Digestive Model
por: Jongjitphisut, Nattapong, et al.
Publicado: (2023)